CSPC Baike (Yantai) Biopharmaceutical
2010
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer and seller of oncology drugs. The company manufactures and sells of oncology drugs including pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) injection and recombinant human granulocyte colony stimulating factor (rhG-CSF) injection.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
CSPC NBP Pharmaceutical
Primary Office
- Yantai
- China
CSPC Baike (Yantai) Biopharmaceutical Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore CSPC Baike (Yantai) Biopharmaceutical‘s full profile, request access.
Request full access to PitchBookCSPC Baike (Yantai) Biopharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore CSPC Baike (Yantai) Biopharmaceutical‘s full profile, request access.
Request full access to PitchBook